Sponsor Check › Person
Related person on Form D filings · address states as listed: CA, FL, MD, NJ · listed Jul 28, 2009 → Nov 24, 2021
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:57 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
No SEC search has run yet for this person.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
2 of 46 offerings report sales commissions totalling $1,180,000; 0 report finder's fees; 4 report proceeds to related persons totalling $3,114,642. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Mar 4, 2022 D File 021-435950 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 24, 2021 D/A File 021-372142 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 27, 2021 D File 021-411490 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 6, 2021 D File 021-405300 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 6, 2021 D File 021-398487 | $0 (est.) | $0 (est.) | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Oct 1, 2020 D File 021-376907 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 21, 2019 D File 021-353952 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 15, 2019 D File 021-346616 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 28, 2018 D File 021-329171 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 12, 2018 D File 021-323465 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 31, 2018 D File 021-313621 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 24, 2018 D File 021-313186 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 12, 2017 D File 021-300471 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 21, 2017 D File 021-299301 | $0 (est.) | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Nov 15, 2017 D File 021-298843 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 10, 2017 D/A File 021-267790 | $0 (est.) | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | May 25, 2017 D/A File 021-265112 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 31, 2017 D File 021-283747 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 6, 2017 D File 021-277831 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 30, 2016 D/A File 021-234314 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 27, 2016 D/A File 021-206072 | $430,000 (est.) | $0 | $1,360,000 (est.) | Piper Jaffray & Co. BrokerCheck CRD 655 ↗ |
| EDGAR ↗ | May 5, 2015 D File 021-239193 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 9, 2015 D/A File 021-232596 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 28, 2014 D/A File 021-178788 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 18, 2013 D File 021-206492 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 12, 2013 D/A File 021-181224 | $750,000 (est.) | $0 | $0 | ROBERTS MITANI, LLC BrokerCheck CRD 30022 ↗ |
| EDGAR ↗ | Jun 4, 2013 D/A File 021-195730 | $0 | $0 | $229,642 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 22, 2012 D File 021-180202 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 21, 2012 D File 021-180116 | $0 | $0 | $800,000 (est.) | None listed on this filing |
| EDGAR ↗ | May 22, 2012 D File 021-178652 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 14, 2011 D File 021-170051 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Dec 5, 2011 D/A File 021-160894 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 25, 2011 D File 021-169229 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 15, 2011 D/A File 021-149681 | $0 | $0 | $725,000 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 14, 2011 D File 021-161241 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Jun 6, 2011 D File 021-160812 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 16, 2011 D File 021-159861 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 25, 2011 D File 021-158825 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 25, 2011 D File 021-158826 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 25, 2011 D File 021-158827 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 4, 2011 D File 021-154828 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 28, 2010 D File 021-141256 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 16, 2010 D/A File 021-102229 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 26, 2009 D/A File 021-87399 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 14, 2009 D File 021-117353 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 27, 2009 D File 021-87118 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Mar 4, 2022 | D | $25,213,472 similar: $2,000,000–$19,999,994 | $23,963,442 | 54 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Revelle Aesthetics, Inc. group: Exploramed | Director | Nov 24, 2021 | D/A | $49,999,996 similar: $829,831–$9,999,998 | $49,999,855 | 36 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Aug 27, 2021 | D | $4,000,000 similar: $2,000,000–$19,999,994 | $3,748,712 | 96 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ANCORA HEART, INC. | Director | Jul 6, 2021 | D | $80,000,000 similar: $829,831–$9,999,998 | $80,000,000 | 47 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | May 6, 2021 | D | $10,845,671 similar: $2,000,000–$19,999,994 | $5,445,363 | 17 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Willow Innovations, Inc. | Director | Oct 1, 2020 | D | $45,169,431 similar: $829,831–$9,999,998 | $32,512,388 | 35 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | Revelle Aesthetics, Inc. group: Exploramed | Director | Jul 30, 2020 | D | $49,999,996 similar: $829,831–$9,999,998 | $24,999,996 | 3 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Nov 21, 2019 | D | $14,765,000 similar: $2,000,000–$19,999,994 | $7,382,500 | 39 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Willow Innovations, Inc. | Director | Aug 15, 2019 | D | $29,478,861 similar: $829,831–$9,999,998 | $22,696,912 | 7 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | ANCORA HEART, INC. | Director | Dec 28, 2018 | D | $35,000,000 similar: $829,831–$9,999,998 | $23,460,256 | 5 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Oct 12, 2018 | D | $21,100,000 similar: $2,000,000–$19,999,994 | $12,360,000 | 29 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ANCORA HEART, INC. | Director | May 31, 2018 | D | $30,000,001 similar: $829,831–$9,999,998 | $17,839,844 | 32 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Earlens Corp | Director | May 24, 2018 | D | $20,000,000 similar: $829,831–$9,999,998 | $9,006,378 | 21 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Willow Innovations, Inc. | Director | Dec 12, 2017 | D | $31,189,200 similar: $829,831–$9,999,998 | $27,470,204 | 12 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Nov 21, 2017 | D | $52,000,000 similar: $2,000,000–$19,999,994 | $3,000,000 | 10 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ExploraMed V, L.L.C. group: Exploramed | Director | Nov 15, 2017 | D | $8,756,650 similar: $829,831–$9,999,998 | $8,756,650 | 28 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Jul 10, 2017 | D/A | $15,000,000 similar: $2,000,000–$19,999,994 | $12,300,000 | 9 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Earlens Corp | Director | May 25, 2017 | D/A | $77,274,197 similar: $829,831–$9,999,998 | $72,121,791 | 59 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Moximed, Inc group: Med Tech Arbitrage | Director | Mar 31, 2017 | D | $51,450,000 similar: $829,831–$9,999,998 | $49,541,720 | 8 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | NEOTRACT INC | Director | Jan 6, 2017 | D | $14,999,999 similar: $829,831–$9,999,998 | $12,816,967 | 12 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Dec 30, 2016 | D/A | $31,000,000 similar: $2,000,000–$19,999,994 | $31,000,000 | 33 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Jul 27, 2016 | D | $10,000,000 similar: $2,000,000–$19,999,994 | $4,000,000 | 4 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Jul 27, 2016 | D/A | $50,796,673 similar: $2,000,000–$19,999,994 | $50,402,467 | 39 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Earlens Corp | Director | Jun 15, 2016 | D | $69,029,068 similar: $829,831–$9,999,998 | $53,593,010 | 22 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Executive Officer, Director | Feb 22, 2016 | D/A | $46,636,324 similar: $2,000,000–$19,999,994 | $44,402,467 | 37 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Moximed, Inc group: Med Tech Arbitrage | Director | May 5, 2015 | D | $37,642,028 similar: $829,831–$9,999,998 | $19,742,755 | 104 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Director | Mar 18, 2015 | D/A | $42,736,324 similar: $2,000,000–$19,999,994 | $38,008,324 | 30 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Willow Innovations, Inc. | Director | Mar 9, 2015 | D/A | $17,500,000 similar: $829,831–$9,999,998 | $17,410,000 | 43 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Feb 19, 2015 | D | $27,000,000 similar: $2,000,000–$19,999,994 | $16,200,000 | 30 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Willow Innovations, Inc. | Director | Jan 21, 2015 | D | $16,000,000 similar: $829,831–$9,999,998 | $15,000,000 | 5 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Director | Mar 12, 2014 | D/A | $26,636,324 similar: $2,000,000–$19,999,994 | $26,636,324 | 27 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | NEOTRACT INC | Director | Jan 28, 2014 | D/A | $56,700,000 similar: $829,831–$9,999,998 | $50,556,684 | 71 similar: 2–15 | $1 similar: $10,000–$54,310 |
| EDGAR ↗ | ARSTASIS INC | Director | Nov 18, 2013 | D | $18,999,998 similar: $829,831–$9,999,998 | $16,499,998 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Director | Nov 8, 2013 | D | $21,637,118 similar: $2,000,000–$19,999,994 | $17,931,354 | 26 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Jul 12, 2013 | D/A | $14,999,994 | $5,195,226 | 11 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Director | Jun 4, 2013 | D/A | $5,470,329 | $4,307,884 | 7 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Director | Apr 29, 2013 | D | $3,000,000 | $1,809,555 | 3 | No minimum reported |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Jul 13, 2012 | D | $14,999,994 | $2,499,999 | 1 | No minimum reported |
| EDGAR ↗ | ARSTASIS INC | Director | Jun 22, 2012 | D | $51,179,299 | $37,837,305 | 14 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Director | Jun 21, 2012 | D | $7,000,000 | $5,000,000 | 13 | No minimum reported |
| EDGAR ↗ | NEOTRACT INC | Director | May 24, 2012 | D | $40,320,000 | $32,399,995 | 12 | $1 |
| EDGAR ↗ | Vibrynt, INc | Director | May 22, 2012 | D | $5,500,000 | $2,750,000 | 5 | $1 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Director | Dec 14, 2011 | D | $35,000,000 | $18,784,666 | 22 | No minimum reported |
| EDGAR ↗ | Moximed, Inc group: Med Tech Arbitrage | Director | Dec 5, 2011 | D/A | $45,862,892 | $45,837,656 | 55 | $1 |
| EDGAR ↗ | ExploraMed IV, L.L.C. group: Exploramed | Director | Nov 25, 2011 | D | $8,000,000 | $6,600,000 | 1 | $1 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Director | Jul 15, 2011 | D/A | $12,000,000 | $9,694,400 | 22 | No minimum reported |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Jun 14, 2011 | D | $5,000,000 | $3,159,325 | 30 | No minimum reported |
| EDGAR ↗ | Moximed, Inc group: Med Tech Arbitrage | Director | Jun 7, 2011 | D | $45,300,000 | $43,269,656 | 6 | $2 |
| EDGAR ↗ | ARSTASIS INC | Director | Jun 6, 2011 | D | $25,521,743 | $25,521,743 | 12 | No minimum reported |
| EDGAR ↗ | Vibrynt, INc | Director | May 16, 2011 | D | $11,500,000 | $11,500,000 | 5 | $1 |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Apr 25, 2011 | D | $1,375,000 | $1,375,000 | 22 | No minimum reported |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Apr 25, 2011 | D | $348,000 | $348,000 | 16 | No minimum reported |
| EDGAR ↗ | VASCULAR THERAPIES INC group: Vascular | Director | Apr 25, 2011 | D | $646,340 | $646,340 | 23 | No minimum reported |
| EDGAR ↗ | NEOTRACT INC | Director | Feb 4, 2011 | D | $27,331,840 | $25,999,999 | 5 | $1 |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Director | Oct 27, 2010 | D | $6,000,000 | $4,492,700 | 14 | No minimum reported |
| EDGAR ↗ | ANCORA HEART, INC. | Director | Apr 28, 2010 | D | $29,999,998 | $29,999,998 | 1 | No minimum reported |
| EDGAR ↗ | SVELTE MEDICAL SYSTEMS INC | Director | Mar 16, 2010 | D/A | $10,000,000 | $4,151,043 | 22 | No minimum reported |
| EDGAR ↗ | NEOTRACT INC | Director | Oct 26, 2009 | D/A | $30,240,000 | $28,108,160 | 15 | $1 |
| EDGAR ↗ | Moximed, Inc group: Med Tech Arbitrage | Director | Aug 14, 2009 | D | $11,000,000 | $10,000,000 | 2 | $2 |
| EDGAR ↗ | NEOTRACT INC | Director | Jul 28, 2009 | D | $25,200,000 | $23,733,044 | 3 | $1 |
| EDGAR ↗ | ARSTASIS INC | Director | Apr 27, 2009 | D | $22,400,005 | $22,400,005 | 13 | $11 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
People and management entities the issuers listed as related persons on the same Form D filings as Robert W. Croce. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Robert W. Croce appears on a new Form D, or when a court case or SEC action is matched to them. See plans →